Insulin glargine and lixisenatide Subcutaneous and Vanacof CD
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Vanacof CD and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: codeine / dexchlorpheniramine / phenylephrine
Brand name: Pro-Red AC, Vanacof CD
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Vanacof DM
- Insulin glargine and lixisenatide Subcutaneous-Vanacof G
- Insulin glargine and lixisenatide Subcutaneous-Vanacof-8
- Insulin glargine and lixisenatide Subcutaneous-Vanadom
- Insulin glargine and lixisenatide Subcutaneous-Vanahist PD
- Insulin glargine and lixisenatide Subcutaneous-Vanamine PD
- Vanacof CD-Insulin glargine, recombinant Subcutaneous
- Vanacof CD-Insulin glulisine
- Vanacof CD-Insulin Glulisine (Cartridges and Pens)
- Vanacof CD-Insulin Glulisine (Vials)
- Vanacof CD-Insulin glulisine Subcutaneous
- Vanacof CD-Insulin human inhaled Inhalation